ZVRA

Conviction 80HealthcareScan · Fri, Jun 26, 2026

ZVRA$13.50+2.04%

ResistanceSupportVol 14Insider sell

Vol MA14 2M

Mar 27Apr 15May 4May 20Jun 9Jun 26

ZEVRA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.zevra.com ↗

Price13.50

Change+2.04%

Gap+0.15%

Rel volume0.69×

Avg volume1.94M

Avg $ vol24.21M

SMA 2012.39

SMA 5011.28

SMA 2009.70

Price vs 50+19.68%

Price vs 200+39.15%

MA stackbullish

50/200 cross—

Supertrendup · 11.58

RSI (14)66

MACD hist0.04

MACD cross—

Stoch %K / %D79 / 74

ADX (14)32

+DI / −DI34 / 15

RSI divergence—

MACD divergence—

ATR %+4.86%

ADR %5.52%

52w high13.66

52w low7.23

From 52w high-1.17%

Above 52w low+86.72%

New 52w highNo

SqueezeOff

Bollinger width29.79%

%B0.80

Donchian pos80.33%

Donchian high14.27

Donchian low10.36

AVWAP (52w high)13.04

vs AVWAP high+3.50%

AVWAP (52w low)10.03

vs AVWAP low+34.63%

OBV trendFlat

Chaikin MF (20)-0.05

Today vs 20d0.69×

Avg vol (14d)2M

Avg vol (20d)1.94M

Avg $ vol (20d)24.21M

Market cap—

RS 3m (vs SPY)+33.11%

RS 6m (vs SPY)+47.51%

RS line new highNo

Trend template8/8

Technical rank91.7

1 week+4.65%

1 month+23.29%

3 months+43.62%

6 months+58.26%

1 year+44.69%

YTD+61.87%

P/E9.39

P/B3.80

P/S—

P/FCF-321.33

EPS1.35

Div yield—

ROE40.44%

ROA29.88%

Debt/Eq0.00

Current4.89

EV/EBITDA-11.65

Gross margin—

Net margin—

Rev growth—

EPS growth178.88%

Price target28.25

Target upside113.61%

Analyst ratingBuy

Institutional75.44%

Ent. value686.2M

Revenue0

Net income37.89M

Gross profit—

Free cash flow-2.43M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out59.12M

Employees61

ListedThu, Apr 16, 2015

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank91.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance13.17

Support10.02

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZVRA

All disclosures →

No recent disclosed trades by Congress in ZVRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZVRA · 8 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
FAVORITO TAMARA A Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Anderson Thomas Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Calder Douglas W Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Secor Alicia Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Shih Alvin Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Watton Corey Michael Director · Stock Option (right to buy) · 2026-06-04	Grant	30K	—	2026-06-04	2026-06-18
Sangiovanni Timothy J. SVP, Finance & Corp Controller · Stock Option (right to buy) · 2026-05-28	Grant	40K	$0	2026-05-28	2026-05-29
Sangiovanni Timothy J. SVP, Finance & Corp Controller · Restricted Stock Unit · 2026-05-28	Grant	20K	$0	2026-05-28	2026-05-29
Thompson Rahsaan Chief Legal & Compliance · Common Stock · 2026-05-11	Sell	1.79K	$20K	2026-05-11	2026-05-13

SEC filings

EDGAR filings in ZVRA · 1 recent

EDGAR →

8-K8-KFri, Jun 5, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.